Brace Yourself for Jeff Bezos' "Amazon Helios"

Amazon delivers 20 million packages a day... powers some of the most popular websites... delivers medication to half of the U.S. population... and even produces award-winning films and TV shows. But a Wall Street legend -- twice featured on 60 Minutes -- predicts that "Amazon Helios" will be bigger than all of those... COMBINED.

IOVA
Iovance Biotherapeutics Inc
NASDAQ
3.17
Open 3.18 Prev Close 3.13
High 3.31 Low 3.08
Volume 26,676,777 Volume (Avg) 10,069
52 Week High 12.51 52 Week Low 2.70
Market Cap 1.1B PE Ratio

Shares Stats

Shares Outstanding305,250,000
Shares Float270,440,000
Shares Short71,370,000
Insider Holdings45%
Institution Holdings82.35%

About Iovance Biotherapeutics Inc

Iovance Biotherapeutics, Inc., a commercial-stage biopharmaceutical company, develops and commercializes cell therapies using autologous tumor infiltrating lymphocyte for the treatment of metastatic melanoma and other solid tumor cancers in the United States. The company offers Amtagvi, a tumor-derived autologous T cell immunotherapy used to treat adult patients with unresectable or metastatic melanoma; and Proleukin, an interleukin-2 product for the treatment of patients with metastatic melanoma and metastatic renal cell carcinoma. It develops lifileucel for treatment of melanoma, cervical cancer, non-small cell lung cancer (NSCLC), endometrial cancer, and head and neck squamous cell carcinoma; IOV-2001 to treat chronic lymphocytic leukemia and small lymphocytic lymphoma; IOV-4001 for the treatment of melanoma and NSCLC; and IOV-3001, an antibody cytokine engrafted protein for use in the TIL therapy treatment regimen. The company has collaborations and licensing agreements with WuXi Advanced Therapies, Inc.; National Institutes of Health; the National Cancer Institute; H. Lee Moffitt Cancer Center; The University of Texas M.D. Anderson Cancer Center; Cellectis S.A.; Novartis Pharma AG; and Boehringer Ingelheim Biopharmaceuticals GmbH. The company was formerly known as Lion Biotechnologies, Inc. and changed its name to Iovance Biotherapeutics, Inc. in June 2017. Iovance Biotherapeutics, Inc. was incorporated in 2007 and is headquartered in San Carlos, California.

General

NameIovance Biotherapeutics Inc
TickerIOVA
ExchangeNASDAQ
SectorHealthcare
IndustryBiotechnology
CurrencyUSD
CountryUSA
Fiscal Year EndDecember
Full Time Employees838

Highlights

Analyst Target20.08
Market Cap1,058,600,000
EBITDA-362,108,992

Financials

Curr Year EPS Estimate-0.78
Next Quarter EPS Estimate-0.26
Profit Margin-226.84%
Operating Margin-240.92
Return on Assets-0.29
Return on Equity-0.57
Revenue164.1M
Earnings Per Share-1.28
Revenue Per Share0.57
Gross Profit40,075,000
Quarterly Revenue Growth151.89

Valuation

Price/Sales (Trailing 12 Mt.)7.12
Price/Book (Most Recent Quarter)1.65

Earnings

Most Popular

Warren Buffett's Top Stock Picks Now Come With a 15% Income Bonus Through This Fund

A new ETF is offering investors the chance to follow in the footsteps of one of the world's most successful investors and earn income at the same time.

Why Barrick Gold Stock Is Trading Lower

Barrick Gold Corp (NYSE:GOLD) shares are trading lower by 4.5% to $19.08 during Wednesday’s session.

Gold Is Being Poured. the Market Hasn't Reacted. - Ad

A test mining program just demonstrated that an experienced mining team has unlocked the value in a built mine atop a high-grade gold deposit. Ore's already been processed. But the stock is still trading like it's early stage. That won't last long.

Musk's Ex-Wife Opens Up About Why Life With Elon Was So Difficult

Justine Wilson recently shed light on the complexities of their marriage and the challenges she faced being married to the Tesla CEO.

Gold's Historic Surge Unlocking Value in These Mining Stocks

Surging gold prices have amplified the profitability of global gold mining companies. Here are some stocks to consider.

The Most Important "AI Stock" You've Never Heard Of - Ad

The AI revolution is moving faster than anyone expected. But what no one is talking about is the one company AI simply can't exist without. It may be the single most important AI investment, yet most people don't even know its name. For now. The moment Wall Street catches on, this $20 stock could explode.

Trump Says 'I Run The Country And The World,' Yet Polls Plummet

The Atlantic published an in-depth interview with President Donald Trump on Monday, marking the first 100 days of his second term in the White House. 

Bill Gates Says 'Luckily' His Daughter Phoebe Gates Never Asked Him To Back Her Business

Bill Gates is glad his daughter Phoebe never asked him to back her business, as it could have complicated their relationship.

The Cross-Chain Giant Set for 1,000%+ Gains - Ad

This multi-chain protocol's volume is exploding while its price is still under the radar. Institutions are moving in fast-get our urgent report before retail wakes up.

Alexandria Ocasio-Cortez Asks,'How Much Did Majorie Taylor Greene Make When She Bought The Dip?'

"Just how much did Marjorie Taylor Greene make when she bought the dip?" Alexandria Ocasio-Cortez asks in the caption of a YouTube video calling for a ban on Congressional trading.

Trump's Autonomous Vehicles Stance, Bezos Vs. Tesla, And More: This Week In Mobility

Autonomous driving & EV have seen significant developments this week: Trump's change of heart, Bezos-backed startups, & Tesla's declining sales.

You Can Take a Stake in Elon's xAI Before June 1st... - Ad

Elon Musk's private AI firm xAI may have just leapfrogged ChatGPT and Google's Gemini--building what experts call the future of AI. For the first time, you can take a stake starting at $500.

Jeff Bezos Wants To Send You To Space After Katy Perry: Here's How Much A Reservation With Blue Origin Costs

Blue Origin is taking reservations for its next trips to space after sending pop star Katy Perry there. Here's how much a reservation costs.

Take Investment Advice From Shaq — His Fortune Grew Thanks To Charles Barkley and Donuts

Former NBA player Shaquille O'Neal has seen a significant increase in his wealth, quadrupling his net worth through an investment strategy inspired by Amazon's CEO, Jeff Bezos.

"Market Wizard " Thrives on Tariff Turmoil - Ad

Steel. Copper. Semiconductors. Another round of tariffs is rattling Wall Street, triggering panic selling. But history shows these policy moves don't just create losers - they create massive trading opportunities.

Eli Lilly Set To Report Earnings As Investors Eye Weight Loss Drug Momentum

Eli Lilly (LLY) will report Q1 results on Thursday. Analysts expect in line results with focus on tirizepatide and obesity franchise.

China's Chip Breakthrough Without ASML Makes Chamath Palihapitiya Take Stock Of Beijing's 'Formidable' Nature: 'America Can Win If…'

Former Intel executive William Huo highlights China's breakthrough in producing 5nm chips without EUV technology, sparking concerns from Chamath Palihapitiya that the U.S. risks losing its technological edge to China without urgent innovation.

No.1 Opportunity for 2025 [Take Action Now!] - Ad

Starlink's potential IPO Could Be the Biggest in History--Silicon Valley insider James Altucher has uncovered a way to profit BEFORE the IPO--with as little as $50. Musk's $180B giant is set to launch--will you miss out? Claim your spot before it's too late.

Activists to rally worldwide on May Day, with US protests targeting Trump policies

CHICAGO (AP) — From worker rights rallies to marches for social justice, activists around the globe will kick off demonstrations on Thursday.

Executive Order 14179 Could Change Social Security Forever - Ad

President Trump's inner circle has a plan that could radically change how Social Security works. In fact, just days after taking office, President Trump signed Executive Order 14179 - giving his team new powers to permanently reset how many key federal agencies work. That reset is now ready to begin... and it's critical you start preparing your money immediately.

Trump's AI Education Push, Cramer's AI Stock Optimism, And More: This Week In Artificial Intelligence

Week full of AI news: Trump advocates for AI education, Cramer bullish on AI stocks, Amazon and Nvidia dismiss data center fears, OpenAI's restructuring raises concerns, Nadella's Microsoft introduces AI updates.

Tens of thousands of Los Angeles County workers begin 2-day strike

LOS ANGELES (AP) — More than 50,000 Los Angeles county workers began a two-day strike Monday evening, closing libraries and disrupting administrative operations across the nation's most populous county.

Elon's Greatest Invention... Hidden in South Memphis? - Ad

Tech legend Jeff Brown recently traveled to the industrial zone of South Memphis to investigate what he believes will be Elon's greatest invention ever... Yes, even bigger than Tesla or SpaceX.

Eliott to celebrate NAPA's 100th anniversary with gold car. Credits company for his NASCAR career

CHARLOTTE, N.C. (AP) — Chase Elliott, son of a NASCAR Hall of Famer and the sport's most popular driver, has 19 career Cup Series wins and championship titles in both the Cup and Xfinity Series.

World Economic Forum: "Arguably the Most Exciting Human Discovery Since Fire" - Ad

Sam Altman, Bill Gates, and Mark Zuckerberg are all investing vast sums of money into a radical technology. According to Bloomberg, this could become 10 times bigger than AI, quantum computing, electric vehicles, cryptocurrencies, and robotics combined. And one stock is at the center of it all.

A New Gold Discovery in Red Lake? - Ad

Two new gold anomalies just lit up the maps. They sit right beside a restart-ready mine-and follow the exact fold pattern that's made Red Lake world famous.

World Liberty's Stablecoin In $2 Billion Deal, SoFi Reintroduces Crypto And Riot Platforms' Q1 Results: This Week In Crypto

The weekend was a whirlwind of activity in the financial world, with a particular focus on cryptocurrencies. From Peter Schiff’s surprising preference for Dogecoin over Bitcoin to Riot Platforms’ Q1 results, there was no shortage of intriguing developments. Let’s dive into the top stories. Peter Schiff Prefers Dogecoin Over Bitcoin

Nvidia Is About to Shock the World: July 23rd - Ad

Jeff Brown, the tech legend who picked shares of Nvidia in 2016 before they jumped by more than 22,000%, is warning everyone to... Mark this date on your calendar: July 23rd! That's when Nvidia could help send shares of this Elon Musk supplier skyrocketing higher.

Gold Is Breaking Records. This Stock Hasn't Moved Yet. - Ad

With gold over $3,200, one near-term producer is still trading like a developer. But the mill is running, crews are working underground, and first production is months away.

Treasury Sec Scott Bessent: US Should Be The 'Premier Destination For Digital Assets'

U.S. Treasury Sec. Bessent advocates for American leadership in digital assets and Congress progresses towards solid crypto market structure.

CEOs Say Container Trade Growth Increasingly Tracks Global GDP, But Tariff Risks Loom

CEOs say that container trade growth is increasingly tracking global GDP, signaling a stable market, but tariff risks loom.

Brace Yourself for Jeff Bezos' "Amazon Helios" - Ad

Amazon delivers 20 million packages a day... powers some of the most popular websites... delivers medication to half of the U.S. population... and even produces award-winning films and TV shows. But a Wall Street legend -- twice featured on 60 Minutes -- predicts that "Amazon Helios" will be bigger than all of those... COMBINED.

AI developers should counter misinformation and protect fact-based news, global media groups say

GENEVA (AP) — A global group of broadcasters and publishers is calling on artificial intelligence developers to make sure their technology serves the public by helping to counter misinformation and protect the value of fact-based news.

Most Recent

Information, charts or examples are for illustration and educational purposes only and not for individualized investment management This message contains commercial elements, such as advertising. We only send these offers to those who have opted in to our newsletter. Past performance is not indicative of future results. For these reasons we strongly suggest trading in a DEMO/Simulated account. The information provided by us is for educational and informational purposes only. We make no representations or warranties concerning the products, practices or procedures of any company or entity mentioned or recommended and have not determined if the statements and opinions of the advertiser are accurate, correct or truthful. If you use, act upon or make decisions in reliance on information contained or any external source linked within it, you do so at your own peril and agree to hold us, our officers, directors, shareholders, affiliates and agents without fault.

Copyright trendadvisor.net
Privacy Policy | Terms of Service